| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1083845693 |
| P356 | DOI | 10.1007/S11010-017-2955-7 |
| P932 | PMC publication ID | 5437150 |
| P698 | PubMed publication ID | 28210898 |
| P50 | author | Joanna Rywaniak | Q39064807 |
| Marta Niwald | Q57560574 | ||
| Michał Bijak | Q61150133 | ||
| Elżbieta Miller | Q87774930 | ||
| P2093 | author name string | Joanna Saluk | |
| Agnieszka Morel | |||
| P2860 | cites work | Evidence of platelet activation in multiple sclerosis | Q21245238 |
| Platelet adhesiveness in multiple sclerosis | Q43905049 | ||
| Overlapping roles of P-selectin and alpha 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis | Q44049997 | ||
| Multiple sclerosis clinical course and cardiovascular disease risk - Swedish cohort study | Q44567736 | ||
| Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort | Q44699939 | ||
| Platelet interleukin-1alpha drives cerebrovascular inflammation | Q48284986 | ||
| Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients | Q48960802 | ||
| Platelet chemokines in health and disease. | Q50893679 | ||
| Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab. | Q51697140 | ||
| Plasma levels of soluble adhesion molecules sPECAM-1, sP-selectin and sE-selectin are associated with relapsing-remitting disease course of multiple sclerosis | Q59273848 | ||
| Flow cytometric parameters for characterizing platelet activation by measuring P-selectin (CD62) expression: theoretical consideration and evaluation in thrombin-treated platelet populations | Q73492432 | ||
| Organization of the glycoprotein (GP) IIb/IIIa heterodimer on resting human platelets studied by flow cytometric energy transfer | Q77363476 | ||
| Multiple sclerosis | Q94019542 | ||
| Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis | Q21343009 | ||
| Defining the clinical course of multiple sclerosis: the 2013 revisions | Q22241654 | ||
| Progressive multiple sclerosis | Q26861772 | ||
| Intrinsic activating properties of GP IIb/IIIa blockers | Q28189326 | ||
| Platelet P-selectin levels in relation to plasma soluble P-selectin and beta-thromboglobulin levels in atrial fibrillation | Q28192920 | ||
| Platelets, inflammation and tissue regeneration | Q28235158 | ||
| A molecular trio in relapse and remission in multiple sclerosis | Q28245076 | ||
| Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis | Q29620481 | ||
| Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. | Q33319975 | ||
| Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers | Q33435650 | ||
| Environmental factors and multiple sclerosis severity: a descriptive study. | Q33834066 | ||
| Defining a role for laquinimod in multiple sclerosis | Q33847350 | ||
| The level of isoprostanes as a non-invasive marker for in vivo lipid peroxidation in secondary progressive multiple sclerosis | Q34890688 | ||
| Relationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive Stage | Q35598836 | ||
| Aspirin and multiple sclerosis | Q35678040 | ||
| Effect of short-term cryostimulation on antioxidative status and its clinical applications in humans | Q35884324 | ||
| Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis. | Q35994186 | ||
| Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis | Q36055389 | ||
| The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms | Q36205278 | ||
| Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation. | Q36471613 | ||
| Platelets as mediators of inflammation | Q36720126 | ||
| Cell-derived microparticles and exosomes in neuroinflammatory disorders | Q36832898 | ||
| Adhesion mechanisms in platelet function | Q36856340 | ||
| The role of microparticles in inflammation and thrombosis | Q36884498 | ||
| The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients. | Q37191533 | ||
| Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis | Q37541906 | ||
| Potential roles of cell-derived microparticles in ischemic brain disease | Q37590447 | ||
| Progressive multiple sclerosis. | Q37591982 | ||
| Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis | Q37838439 | ||
| Progressive multiple sclerosis: pathology and pathogenesis | Q38046113 | ||
| Platelets: bridging hemostasis, inflammation, and immunity | Q38099418 | ||
| Platelets and autoimmunity. | Q38101678 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1-2 | |
| P921 | main subject | flow cytometry | Q1141429 |
| P304 | page(s) | 69-80 | |
| P577 | publication date | 2017-02-16 | |
| P1433 | published in | Molecular and Cellular Biochemistry | Q1573176 |
| P1476 | title | Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients | |
| P478 | volume | 430 |
| Q98726775 | Blood platelet RNA enables the detection of multiple sclerosis |
| Q92730704 | Extracellular Vesicles in the Blood of Dogs with Cancer-A Preliminary Study |
| Q91450933 | Flow cytometry for near-patient testing in premature neonates reveals variation in platelet function: a novel approach to guide platelet transfusion |
| Q64063528 | Increased level of fibrinogen chains in the proteome of blood platelets in secondary progressive multiple sclerosis patients |
| Q98619283 | Metformin as a Potential Agent in the Treatment of Multiple Sclerosis |
| Q97523765 | Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis |
| Q64244981 | Platelet Depletion is Effective in Ameliorating Anxiety-Like Behavior and Reducing the Pro-Inflammatory Environment in the Hippocampus in Murine Experimental Autoimmune Encephalomyelitis |
| Q93342943 | Platelet-Neutrophil Interactions Are Lower in Cord Blood of Premature Newborns |
| Q64245719 | Pro-Thrombotic Activity of Blood Platelets in Multiple Sclerosis |
| Q92604452 | Salvianolic acid a inhibits platelet activation and aggregation in patients with type 2 diabetes mellitus |
| Q48275617 | Thrombin generation correlates with disease duration in multiple sclerosis (MS): Novel insights into the MS-associated prothrombotic state |
Search more.